glp-1 agonist cardiovascular outcomes outcome studies with receptor Beyond GLP1: modulating multiple nutrient-stimulated

& Mantzoros, C

The study, published in Nature Health , analyzed over five years of discussions from nearly 70,000 Reddit users

Prior to the weighting of covariates, GLP-1 receptor agonist users were more likely to be obese, diagnosed with T2D for a longer duration, and female as compared to those prescribed SGLT-2 inhibitors

This article aims to demystify GLP-1 receptor agonists, explaining their mechanism, benefits, and the reasons behind their growing popularity

[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Ferrannini E., Baldi S., Frascerra S., Astiarraga B., Heise T., Bizzotto R., Mari A., Pieber T.R., Muscelli E

As our results are based on US data, they may not be directly transferable to other countries with different health care systems and cost structures